South-Asian population has a higher likelihood for diabetes risk for statins regardless of potency.
Higher potency statins are associated with increased risk of new-onset diabetes (NOD) in Western populations. South-Asians phenotype, with certain unique features such as young onset of diabetes and lower threshold for diabetes risk factors, present a higher likelihood for NOD risk for statins regardless of potency.